Inventor · disambiguated record
Terry L. Bowlin
Also filed as: BOWLIN TERRY L
12 granted patents·3 pending applications·194 citations·filing 1987–2020
92Inventor score
Files withMERRELL DOW PHARMA5MERRELL PHARMA INC4MICROBIOTIX INC4BASU ARNAB1MERRELL PHAMACEUTICALS INC1
Top patents by PatentIndex Score
15 records- 0192US5109024APolyamine derivatives as antineoplastic agentsMERRELL DOW PHARMA·Filed 1991·Granted Apr 28, 1992·46 cites·26 claims
- 0277US5013719AMethod of effecting immunosuppressionMERRELL DOW PHARMA·Filed 1988·Granted May 7, 1991·23 cites·1 claims
- 0372US9212134B2Inhibitors of viral entry into mammalian cellsBASU ARNAB·Filed 2011·Granted Dec 15, 2015·3 cites·11 claims
- 0472US5654287AMethod of treating cancer by conjunctive therapy with N,N1 -bis[3-(ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agentMERRELL PHAMACEUTICALS INC·Filed 1995·Granted Aug 5, 1997·32 cites·10 claims
- 0569US5004746AAnti-retroviral castanospermine estersMERRELL DOW PHARMA·Filed 1987·Granted Apr 2, 1991·15 cites·28 claims
- 0664US5002879ATreatment of tumors with autologous LAK cells, interleukin-2 and an ornithine decarboxylase inhibitorMERRELL DOW PHARMA·Filed 1989·Granted Mar 26, 1991·28 cites·2 claims
- 0763US5719193AMethod of potentiating cell-mediated immunity utilizing polyamine derivativesMERRELL PHARMA INC·Filed 1995·Granted Feb 17, 1998·26 cites·32 claims
- 0847US2022370464A1Compositions and methods of treating or preventing ocular infections with filociclovirMICROBIOTIX INC·Filed 2020·Application pending·0 cites
- 0946US2022152028A1Combination drug treatment for human cytomegalovirusMICROBIOTIX INC·Filed 2020·Application pending·0 cites
- 1045US5635218AMethod of treating cancer by conjunctive therapy with N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agentMERRELL PHARMA INC·Filed 1995·Granted Jun 3, 1997·6 cites·12 claims
- 1143US5646124AMethod of treating cancer by conjunctive therapy with N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agentMERRELL PHARMA INC·Filed 1995·Granted Jul 8, 1997·5 cites·12 claims
- 1241US5308837A5'-amine substituted adenosine analogs as immunosuppressantsMERRELL DOW PHARMA·Filed 1992·Granted May 3, 1994·8 cites·8 claims
- 1338US11459308B2Broad spectrum inhibitors of filovirusesMICROBIOTIX INC·Filed 2017·Granted Oct 4, 2022·0 cites·41 claims
- 1438US2022168310A1Inhibition of adenovirus with filociclovirMICROBIOTIX INC·Filed 2020·Application pending·0 cites
- 1537US5561136AMethod of treating cancer by conjunctive therapy with N,N'-bis[ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agentMERRELL PHARMA INC·Filed 1995·Granted Oct 1, 1996·2 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Terry L. Bowlin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →